ID   HMKOA
AC   CVCL_X938
DR   CGH-DB; 345-2
DR   CGH-DB; 9350-4
DR   Wikidata; Q54889934
RX   CelloPub=CLPUB00154;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 7
//
RX   CelloPub=CLPUB00154;
RA   Ishiwata I., Sato Y., Iguchi M., Tokieda Y., Ishiwata C., Kiguchi K.,
RA   Ishikawa H.;
RT   "Establishment and characterization of two human ovarian mucinous
RT   cystadenocarcinoma cell lines (HMKOA).";
RL   Hum. Cell 12 Suppl. 1:59.1-59.1(1999).
//
RX   PubMed=11330945; DOI=10.1006/gyno.2001.6132;
RA   Watanabe T., Imoto I., Kosugi Y., Ishiwata I., Inoue S., Takayama M.,
RA   Sato A., Inazawa J.;
RT   "A novel amplification at 17q21-23 in ovarian cancer cell lines
RT   detected by comparative genomic hybridization.";
RL   Gynecol. Oncol. 81:172-177(2001).
//
RX   PubMed=12417041; DOI=10.1111/j.1349-7006.2002.tb01213.x; PMCID=PMC5926887;
RA   Watanabe T., Imoto I., Katahira T., Hirasawa A., Ishiwata I., Emi M.,
RA   Takayama M., Sato A., Inazawa J.;
RT   "Differentially regulated genes as putative targets of amplifications
RT   at 20q in ovarian cancers.";
RL   Jpn. J. Cancer Res. 93:1114-1122(2002).
//
RX   PubMed=17671176; DOI=10.1158/0008-5472.CAN-06-4567;
RA   Kikuchi R., Tsuda H., Kanai Y., Kasamatsu T., Sengoku K.,
RA   Hirohashi S., Inazawa J., Imoto I.;
RT   "Promoter hypermethylation contributes to frequent inactivation of a
RT   putative conditional tumor suppressor gene connective tissue growth
RT   factor in ovarian cancer.";
RL   Cancer Res. 67:7095-7105(2007).
//